𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimal Vascular Protection: A Case for Combination Antihypertensive Therapy

✍ Scribed by Robert A Vogel

Book ID
115304758
Publisher
Le Jacq Communications, Inc.
Year
2006
Tongue
English
Weight
212 KB
Volume
9
Category
Article
ISSN
1520-037X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

IBD: A vascular disorder? the case for h
IBD: A vascular disorder? the case for heparin therapy
✍ Dr. Joshua R. Korzenik πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 864 KB

In recent years, heparin has emerged as a possible therapy for inflammatory bowel disease (IBD). Several recent, strongly positive, open-labeled series of heparin in both ulcerative colitis (UC) and Crohn's disease (CD) reinforce the work of Gaffney and co-workers that suggested a benefit of heparin

Combined vascular targeted imaging and t
Combined vascular targeted imaging and therapy: A paradigm for personalized treatment
✍ King C.P. Li; Samira Guccione; Mark D. Bednarski πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 1 views

In order to be successful in personalizing treatment, methods for selecting patients as well as good surrogate biomarkers for monitoring the effects of treatment are required in addition to development of an efficacious targeted therapy. We have developed a polymerized nanoparticle platform technolo

Resistance of HBV to adefovir dipivoxil:
Resistance of HBV to adefovir dipivoxil: A case for combination antiviral therapy?
✍ Costica Aloman; Jack R. Wands πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Background & Aims: Adefovir dipivoxil effectively inhibits both hepatitis B virus (HBV) replication and disease activity in patients with chronic hepatitis B. Resistance to treatment was not observed in 2 recent large placebo-controlled 48-week studies with this drug. The aim of this study was to ch